封面
市场调查报告书
商品编码
1606537

全球手术网片市场 - 2024-2031

Global Surgical Mesh Market - 2024-2031

出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年,全球手术网片市场达到19.0亿美元,预计2031年将达到32.2亿美元,2024-2031年预测期间复合年增长率为6.9%。

手术网片是一种用于外科手术的医疗器械,可为虚弱或受损的组织提供额外的支撑。它通常是由合成或生物材料製成的柔性片状结构,旨在在癒合过程中加固和稳定组织。手术网片广泛应用于各种外科手术,包括疝气修补、骨盆器官脱垂(POP)修復、压力性尿失禁(SUI)治疗和其他重建手术​​。网片有多种结构,例如单丝、复丝和复合网片,以满足特定的手术需求。

多年来,尤其是由于疝气修復手术的不断增加,手术网片市场的需求量很大。例如,根据美国食品药物管理局 (FDA) 的数据,美国每年进行超过 100 万例疝气修补手术,而全世界每年此类手术估计超过 2,000 万例,这些修復手术涉及使用手术网片,使其成为疝气手术的护理标准,导致手术网片的需求增加。

市场动态:

驱动程式和限制

疝气盛行率上升

疝气盛行率的上升极大地推动了手术网片市场的发展,因为疝气修復是网状植入物最常见的手术应用之一。疝气是一种器官或组织经由周围肌肉或结缔组织的薄弱点凸出的疾病。例如,aLLSurgical 网片用于加强薄弱区域,确保更好的恢復效果并降低復发风险。

此外,疝气修补术是全世界最常见的手术类型之一。根据美国食品药物管理局 (FDA) 统计,全球每年进行约 2,000 万例疝气修復手术。这种高产量直接推动了对这些手术中使用的手术网片的需求,特别是腹股沟、脐和腹部疝气。

手术网片被认为是疝气修復的黄金标准,因为它能够为组织提供长期加固。 80% 的疝气修补手术都涉及使用补片,因为它有助于防止復发并加速恢復。疝气手术中对网状植入物的偏好极大地促进了手术网状市场的成长。

併发症和安全问题

与手术网片相关的併发症和安全问题预计将阻碍手术网片市场的成长。这些担忧围绕着网片迁移、感染、侵蚀、慢性疼痛和长期健康併发症等问题,所有这些都可能导致患者出现负面结果并增加医疗费用。围绕手术网片的不良事件和安全问题日益增多,引发了监管审查和法律挑战,这可能会减缓网片产品的采用。

当网状材料降解或从其原始位置移动时,就会发生网状侵蚀,导致其嵌入附近的组织或器官。这可能导致严重的併发症,例如感染、慢性疼痛和组织损伤。同样,网片迁移是指网片偏离其预期位置的移动,这也可能导致内部损坏并需要进行矫正手术。

例如,研究显示 5% 至 20% 的疝气手术会导致补片失败。根据《英国医学杂誌》的一项研究,这一比例可能在 12% 到 30% 之间。这些併发症可能需要进行翻修手术,这会增加医疗费用和患者发病率。

目录

第 1 章:方法与范围

第 2 章:定义与概述

第 3 章:执行摘要

第 4 章:动力学

  • 影响因素
    • 司机
      • 疝气盛行率上升
      • 外科网片设计不断创新
    • 限制
      • 併发症和安全问题
    • 机会
    • 影响分析

第 5 章:产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 专利分析
  • 监管分析
  • SWOT分析
  • 未满足的需求

第 6 章:依产品类型

  • 可吸收手术网片
  • 不可吸收手术网片
  • 生物网
  • 合成网

第 7 章:依材料类型

  • 聚丙烯
  • 聚酯纤维
  • 聚四氟乙烯 (PTFE)
  • 其他的

第 8 章:按申请

  • 疝气修补
  • 骨盆腔器官脱垂修復术
  • 压力性尿失禁
  • 其他的

第 9 章:最终用户

  • 医院
  • 专科诊所
  • 门诊手术中心
  • 其他的

第 10 章:按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 11 章:竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 12 章:公司简介

  • Johnson & Johnson
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • B. Braun SE
  • Medtronic plc
  • Becton, Dickinson and Company
  • CITEC
  • WL Gore & Associates, Inc.
  • Medcity Surgicals
  • Dolphin Sutures
  • Herniamesh Srl
  • Advin Health Care (LIST NOT EXHAUSTIVE )

第 13 章:附录

简介目录
Product Code: MD8845

Overview

The global surgical mesh market reached US$ 1.90 billion in 2023 and is expected to reach US$ 3.22 billion by 2031, growing at a CAGR of 6.9% during the forecast period 2024-2031.

Surgical mesh is a medical device used in surgical procedures to provide additional support to weakened or damaged tissue. It is typically a flexible, sheet-like structure made from synthetic or biological materials and is designed to reinforce and stabilize tissues during healing. Surgical meshes are widely used in various surgical applications, including hernia repair, pelvic organ prolapse (POP) repair, stress urinary incontinence (SUI) treatment and other reconstructive surgeries. Meshes are available in various structures, such as monofilament, multifilament and composite meshes, to cater to specific surgical needs.

The surgical mesh market has witnessed substantial demand over the years owing to the rising hernia repairs, especially. For instance, according to the U.S. Food and Drug Administration (FDA), more than 1 million hernia repairs are performed each year in the United States, and worldwide these surgeries are estimated to top 20 million annually, these repairs involve the use of surgical mesh, making it the standard of care for hernia surgery, contributing to the increasing demand for surgical meshes.

Market Dynamics: Drivers & Restraints

Rising prevalence of hernias

The rising prevalence of hernias is significantly driving the surgical mesh market, as hernia repairs are one of the most common surgical applications for mesh implants. Hernia is a condition in which an organ or tissue bulges through a weak spot in the surrounding muscle or connective tissue. For instance, aLLSurgical mesh is used to reinforce the weakened area, ensuring better recovery outcomes and reducing the risk of recurrence.

Additionally, hernia repairs are among the most common types of surgeries performed worldwide. According to the U.S. Food and Drug Administration (FDA), annually, about 20 million hernia repairs are conducted globally. This high volume directly drives demand for surgical meshes used in these procedures, especially for inguinal, umbilical, and ventral hernias.

Surgical mesh is considered the gold standard for hernia repair due to its ability to provide long-term reinforcement to the tissue. 80% of all hernia repairs involve the use of mesh, as it helps prevent recurrence and speeds up recovery. This preference for mesh implants in hernia surgeries significantly contributes to the growth of the surgical mesh market.

Complications and safety concerns

Complications and safety concerns related to surgical mesh are expected to hamper the growth of the surgical mesh market. These concerns revolve around issues such as mesh migration, infection, erosion, chronic pain and long-term health complications, all of which can lead to negative patient outcomes and increased healthcare costs. The growing number of adverse events and safety concerns surrounding surgical meshes has prompted regulatory scrutiny and legal challenges, which can slow the adoption of mesh products.

Mesh erosion occurs when the mesh material degrades or moves from its original position, causing it to become embedded in nearby tissues or organs. This can lead to severe complications such as infection, chronic pain, and tissue damage. Similarly, mesh migration refers to the movement of the mesh from its intended placement, which can also cause internal damage and necessitate corrective surgery.

For instance, studies suggest that 5% to 20% of hernia operations result in mesh failure. According to a study in the British Medical Journal, the rate could be between 12% and 30%. These complications may require revision surgeries, which can increase both healthcare costs and patient morbidity.

Segment Analysis

The global surgical mesh market is segmented based on product type, material type, application, end-user and region.

Application:

The hernia repair segment is expected to dominate the global surgical mesh market share

The hernia repair segment holds a major portion of the surgical mesh market share and is expected to continue to hold a significant portion of the market share over the forecast period due to the established use of mesh in hernia repair surgeries and the superior outcomes provided by mesh-based procedures compared to traditional non-mesh surgeries. Hernia repair surgeries are the gold standard for reinforcing the weakened abdominal walls and preventing hernia recurrence. Thus, the market players are focusing on surgical mesh development due to its wide advantages.

For instance, in November 2024, Deep Blue Medical expanded its success of T-Line Hernia Mesh, a surgical product that helps prevent the recurrence of hernias after abdominal hernia repair surgery. Although the T-Line Mesh made its clinical debut just three years ago, it is already being used by about 45 clinical sites in the United States and over 8,000 of the novel extensions and lockstitches of the mesh have been implanted to date with no adverse events.

The shift towards minimally invasive hernia repair surgeries, such as laparoscopic and robot-assisted surgery, has contributed to the dominance of the hernia repair segment. Surgical meshes are ideal for use in these procedures because they are lightweight, flexible and can be easily inserted through small incisions.

For instance, laparoscopic hernia repair is becoming the preferred technique for many surgeons due to its lower complication rates and quicker recovery. According to the Global Hernia Society, the laparoscopic approach accounts for about 60-70% of hernia surgeries in developed countries, driving the demand for surgical meshes tailored for these procedures.

With the increasing awareness of hernias and the effectiveness of mesh-based surgeries, more patients are seeking treatment, contributing to the growing demand for hernia repairs using mesh. Additionally, improvements in healthcare access in emerging economies have increased the number of hernia surgeries being performed in those regions.

For instance, in June 2021, BG Medical., the manufacturer and distributor of the 21st Century SURGIMESH Platform honored Hernia Awareness Month by partnering with CQInsights to pioneer a new approach that delivers better outcomes for patients, with a larger mission to share sustainable solutions that improve healthcare for everyone.

North America is expected to hold a significant position in the global surgical mesh market

North America represents the largest share of the global surgical mesh market in terms of both revenue generation and market size. The U.S., in particular, is the largest market within the region, driven by a combination of high demand for surgeries, advanced healthcare technologies, and a well-established healthcare system.

North America, particularly the United States, has a high incidence of hernias due to factors such as an aging population, high obesity rates, and sedentary lifestyles. This has led to a large number of hernia repairs, most of which involve surgical mesh. For instance, according to Healthcare Cost and Utilization Project data and the US Food and Drug Administration, an estimated 611,000 ventral and 1 million inguinal hernia repairs are performed each year in the US.

North America has high levels of healthcare awareness and access, which leads to an increased number of surgeries involving surgical mesh. Patients are more likely to seek treatment for conditions like hernias, knowing that advanced treatments, such as mesh implants, are available. Thus, the market players are focusing on launching the surgical mesh with technological advancements.

For instance, in April 2024, ELA Bio commercially launched the OviTex Inguinal Hernia Repair (IHR) mesh in the US. The Pennsylvania-based firm has specifically designed the robotic-compatible OviTex IHR surgical mesh for use in laparoscopic and inguinal hernia repair. It comes in a three or four layer anatomically shaped device or a three-layer rectangular device.

Asia Pacific is growing at the fastest pace in the surgical mesh market

The Asia Pacific region is experiencing the fastest growth in the surgical mesh market. The rising rates of obesity in countries like China and India, combined with an increasing number of abdominal hernia cases, are driving the demand for hernia repair surgeries. Obesity is a key risk factor for hernias, and with lifestyle changes, these conditions are becoming more prevalent in the Asia Pacific region, creating a significant market opportunity for surgical meshes.

For instance, according to the World Health Organization (WHO), the prevalence of obesity in Asia is rising rapidly. According to the Chinese BMI classification for overweight and obesity, 34.8% of the study population were overweight and 14.1% were obese. This growing rate of obesity significantly contributes to the increasing number of hernia cases and surgeries requiring mesh.

The Asia Pacific region has witnessed significant investments in healthcare infrastructure, particularly in countries like India, China and South Korea, where hospitals, surgical centers and medical device manufacturers are modernizing and expanding. This has made advanced surgical treatments, including mesh-based procedures, more accessible to the growing population.

For instance, in October 2024, Park Hospital, a multi-specialty healthcare provider performed a complex robotic-assisted surgery to save a 45-year-old man from a complicated diaphragmatic hernia. Robotic-assisted surgery allowed to safely reduce the herniated organs back into the abdominal cavity and repair the diaphragm with a large mesh, ensuring a stable closure. This increases the demand for surgical mesh in the region.

Competitive Landscape

The major global players in the surgical mesh market include Johnson & Johnson, B. Braun SE, Medtronic plc, Becton, Dickinson and Company, CITEC, W. L. Gore & Associates, Inc., Medcity Surgicals, Dolphin Sutures, Herniamesh S.r.l., Advin Health Care and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Insights into clinical trials, product pipelines, and upcoming advancements.
  • Market Positioning: Analysis of product performance and growth potential for optimized strategies.
  • Real-World Evidence: Integration of patient feedback for enhanced product outcomes.
  • Physician Preferences: Insights into healthcare provider behaviors and adoption strategies.
  • Regulatory & Market Updates: Coverage of recent regulations, policies, and emerging technologies.
  • Competitive Insights: Analysis of market share, competitor strategies, and new entrants.
  • Pricing & Market Access: Review of pricing models, reimbursement trends, and access strategies.
  • Market Expansion: Strategies for entering new markets and forming partnerships.
  • Regional Opportunities: Identification of high-growth regions and investment prospects.
  • Supply Chain Optimization: Assessment of risks and distribution strategies.
  • Sustainability & Regulation: Focus on eco-friendly practices and regulatory changes.
  • Post-Market Surveillance: Enhanced safety and access through post-market data.
  • Value-Based Pricing: Insights into pharmacoeconomics and data-driven R&D decisions.

The global surgical mesh market report delivers a detailed analysis with 70 key tables, more than 66 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Material Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Prevalence of Hernias
      • 4.1.1.2. Rising Innovations in Surgical Mesh Designs
    • 4.1.2. Restraints
      • 4.1.2.1. Complications and Safety Concerns
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Patent Analysis
  • 5.5. Regulatory Analysis
  • 5.6. SWOT Analysis
  • 5.7. Unmet Needs

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Absorbable Surgical Mesh*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Non-Absorbable Surgical Mesh
  • 6.4. Biological Mesh
  • 6.5. Synthetic Mesh

7. By Material Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.1.2. Market Attractiveness Index, By Material Type
  • 7.2. Polypropylene*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Polyester
  • 7.4. Polytetrafluoroethylene (PTFE)
  • 7.5. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Hernia Repair*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Pelvic Organ Prolapse Repair
  • 8.4. Stress Urinary Incontinence
  • 8.5. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Clinics
  • 9.4. Ambulatory Surgical Centers
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Johnson & Johnson*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. B. Braun SE
  • 12.3. Medtronic plc
  • 12.4. Becton, Dickinson and Company
  • 12.5. CITEC
  • 12.6. W. L. Gore & Associates, Inc.
  • 12.7. Medcity Surgicals
  • 12.8. Dolphin Sutures
  • 12.9. Herniamesh S.r.l.
  • 12.10. Advin Health Care (LIST NOT EXHAUSTIVE )

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us